The impact of growth modulation of liver carcinogenesis
The impact of growth modulation of liver carcinogenesis
批准号:
8237696
负责人:
XIAO-MING YIN
金额:
$9.9万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-07-01 至 2012-05-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Hepatocellular carcinoma (HCC) is a frequent end-stage outcome of many chronic liver diseases, such as viral hepatitis and alcoholic liver disease, and of exposure to chemical carcinogens. The development of liver cancer is a slow process that involves multiple stages of initiation, promotion and progression, encompassing a long period. Molecular events controlling the process have not been fully elucidated, particularly at the early stage of tumor initiation. In a chemical hepatocarcinogenic model employing the classical carcinogen, diethylnitrosamine, we found that deletion of Bid, a pro-death Bcl-2 family protein, paradoxically suppressed the carcinogenesis starting at the early stage of microfoci development, when the capability of hepatocyte proliferation is critically involved. This early effect had a significant impact on overall tumor development examined 8-12 months after diethylnitrosamine administration. Further studies revealed a novel function of Bid in promotion of cell cycle entry and in regulation of intracellular calcium homeostasis. We hypothesize that Bid facilitates the initiation of tumorigenesis by promoting cell proliferation but also exert its pro-apoptosis function in the later stage of tumor development. We are proposing to test this hypothesis through the following approaches: 1) Examination of the effect of Bid in DEN-induced liver tumor paradigms and in mice of different genetic backgrounds that are known to affect the tumor initiation and cell proliferation capability; 2) Determination of the stage-specific effect of Bid on tumor development based on its function in cell proliferation and cell death using inducible transgenic and gene deletion models; 3) Exploration of the mechanisms of Bid in regulating cell cycle progression via its effects on calcium homeostasis in endoplasmic reticulum. We hope that these studies will allow us to achieve our long term goal of understanding how the growth potential of cells affects chemical carcinogenesis, particularly in the liver system, and how this potential is regulated by different genetic elements.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Gene Expression Analysis Indicates Divergent Mechanisms in DEN-Induced Carcinogenesis in Wild Type and Bid-Deficient Livers.
基因表达分析表明野生型和 Bid 缺陷型肝脏中 DEN 诱导的致癌作用存在不同机制。
DOI:
10.1371/journal.pone.0155211
发表时间:
2016
期刊:
PloS one
影响因子:
3.7
作者:
[Yu,Changshun, Yan,Shengmin, Khambu,Bilon, Chen,Xiaoyun, Dong,Zheng, Luo,Jianhua, Michalopoulos,GeorgeK, Wu,Shangwei, Yin,Xiao-Ming]
通讯作者:
Yin,Xiao-Ming
DOI:
10.1016/j.bbrc.2012.07.090
发表时间:
2012-08-31
期刊:
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
影响因子:
3.1
作者:
[Ding, Wen-Xing, Chen, Xi, Yin, Xiao-Ming]
通讯作者:
Yin, Xiao-Ming
DOI:
10.1371/journal.pone.0052347
发表时间:
2012
期刊:
PloS one
影响因子:
3.7
作者:
[Chen X, Li M, Chen D, Gao W, Guan JL, Komatsu M, Yin XM]
通讯作者:
Yin XM
CCCP-Induced LC3 lipidation depends on Atg9 whereas FIP200/Atg13 and Beclin 1/Atg14 are dispensable.
DOI:
10.1016/j.bbrc.2013.02.010
发表时间:
2013-03-08
期刊:
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
影响因子:
3.1
作者:
[Chen, Daohong, Chen, Xi, Li, Min, Zhang, Hao, Ding, Wen-Xing, Yin, Xiao-Ming]
通讯作者:
Yin, Xiao-Ming
The Role of HMGB1 in autophagy deficiency-induced liver pathology
-
批准号:10188516
-
项目类别:
-
资助金额:$40.04万
-
财政年份:2018
-
负责人:XIAO-MING YIN
-
依托单位:
The Role of HMGB1 in autophagy deficiency-induced liver pathology
-
批准号:10137441
-
项目类别:
-
资助金额:$35.35万
-
财政年份:2018
-
负责人:XIAO-MING YIN
-
依托单位:
The Role of HMGB1 in autophagy deficiency-induced liver pathology
-
批准号:9751288
-
项目类别:
-
资助金额:$6.17万
-
财政年份:2018
-
负责人:XIAO-MING YIN
-
依托单位:
Mechanism and role of selective autophagy in ethanol-induced liver injury
-
批准号:8509479
-
项目类别:
-
资助金额:$18.37万
-
财政年份:2014
-
负责人:XIAO-MING YIN
-
依托单位:
Mechanism and role of selective autophagy in ethanol-induced liver injury
-
批准号:8867956
-
项目类别:
-
资助金额:$14.79万
-
财政年份:2014
-
负责人:XIAO-MING YIN
-
依托单位:
High-Content Cell-Based Screening for Modulators of Autophagy
-
批准号:7453976
-
项目类别:
-
资助金额:$2.5万
-
财政年份:2007
-
负责人:XIAO-MING YIN
-
依托单位:
The impact of growth modulation of liver carcinogenesis
-
批准号:7261321
-
项目类别:
-
资助金额:$27.26万
-
财政年份:2005
-
负责人:XIAO-MING YIN
-
依托单位:
The impact of growth modulation of liver carcinogenesis
-
批准号:7430459
-
项目类别:
-
资助金额:$27.26万
-
财政年份:2005
-
负责人:XIAO-MING YIN
-
依托单位:
The impact of growth modulation of liver carcinogenesis
-
批准号:7081233
-
项目类别:
-
资助金额:$28.08万
-
财政年份:2005
-
负责人:XIAO-MING YIN
-
依托单位:
The impact of growth modulation of liver carcinogenesis
-
批准号:7627384
-
项目类别:
-
资助金额:$17.36万
-
财政年份:2005
-
负责人:XIAO-MING YIN
-
依托单位:
The impact of growth modulation of liver carcinogenesis
-
批准号:6968134
-
项目类别:
-
资助金额:$28.75万
-
财政年份:2005
-
负责人:XIAO-MING YIN
-
依托单位:
Bc1-2 Family Proteins in the Ischemic Neuronal Injury
-
批准号:6569380
-
项目类别:
-
资助金额:$24.46万
-
财政年份:2003
-
负责人:XIAO-MING YIN
-
依托单位:
Bc1-2 Family Proteins in the Ischemic Neuronal Injury
-
批准号:7004488
-
项目类别:
-
资助金额:$24.88万
-
财政年份:2003
-
负责人:XIAO-MING YIN
-
依托单位:
Bc1-2 Family Proteins in the Ischemic Neuronal Injury
-
批准号:6697252
-
项目类别:
-
资助金额:$25.67万
-
财政年份:2003
-
负责人:XIAO-MING YIN
-
依托单位:
Bc1-2 Family Proteins in the Ischemic Neuronal Injury
-
批准号:6831662
-
项目类别:
-
资助金额:$25.56万
-
财政年份:2003
-
负责人:XIAO-MING YIN
-
依托单位:
Signal integration of the death receptor pathways
-
批准号:8237720
-
项目类别:
-
资助金额:$15.49万
-
财政年份:2000
-
负责人:XIAO-MING YIN
-
依托单位:
FAS/TNF R1 INITIATED HEPATOCYTE DEATH IN MEDIATE BY BID
-
批准号:6765159
-
项目类别:
-
资助金额:$22.08万
-
财政年份:2000
-
负责人:XIAO-MING YIN
-
依托单位:
FAS/TNF R1 INITIATED HEPATOCYTE DEATH IN MEDIATE BY BID
-
批准号:6377615
-
项目类别:
-
资助金额:$14.85万
-
财政年份:2000
-
负责人:XIAO-MING YIN
-
依托单位:
FAS/TNF R1 INITIATED HEPATOCYTE DEATH IN MEDIATE BY BID
-
批准号:6514224
-
项目类别:
-
资助金额:$21.72万
-
财政年份:2000
-
负责人:XIAO-MING YIN
-
依托单位:
FAS/TNF R1 INITIATED HEPATOCYTE DEATH IN MEDIATE BY BID
-
批准号:6633538
-
项目类别:
-
资助金额:$21.9万
-
财政年份:2000
-
负责人:XIAO-MING YIN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于FP-Growth关联分析算法的重症患者抗菌药物精准决策模型的构建和实证研究
-
批准号:2024Y9049
-
项目类别:省市级项目
-
资助金额:100.0万元
-
批准年份:2024
-
负责人:阮君山
-
依托单位:
含Re、Ru先进镍基单晶高温合金中TCP相成核—生长机理的原位动态研究
-
批准号:52301178
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:夏万顺
-
依托单位:
新型小分子蛋白—人肝细胞生长因子三环域(hHGFK1)抑制破骨细胞及治疗小鼠骨质疏松的疗效评估与机制研究
-
批准号:82370885
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姚晨
-
依托单位:
基于 Klotho 调控 FGF23/SGK1/NF-κB信号通路研究糖尿病肾病血管钙化机制及肾元颗粒干预作用
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2022
-
负责人:
-
依托单位:
非经典TGF-beta信号通路调控小肠干细胞稳态的作用及机制研究
-
批准号:32000538
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:刘连胜
-
依托单位:
mTOR信号通路关键调节蛋白Rheb临近蛋白的筛选及其在细胞衰老中的功能研究
-
批准号:32070778
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:吴苏
-
依托单位:
IQGAP2蛋白在介导R-spondin影响小肠干细胞稳态的作用
-
批准号:31900550
-
项目类别:青年科学基金项目
-
资助金额:26.0万元
-
批准年份:2019
-
负责人:刘媛
-
依托单位:
细胞膜受体调控mTORC2活化的新机制研究
-
批准号:31970717
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:罗永挺
-
依托单位:
生长激素信号降低与肥胖发生关系的分子机制研究
-
批准号:81170814
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:王向东
-
依托单位:
CD4+CD25+调节性T细胞对肿瘤干细胞的影响及其调控机制研究
-
批准号:81171983
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:李慧
-
依托单位: